TRADING UPDATES: MedPal acquisition; Helix begins helium sales
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
| Price | 30.00p on 15-09-2026 at 18:15:10 |
|---|---|
| Change | -1.50p -4.76% |
| Buy | 31.00p |
| Sell | 29.00p |
| Last Trade: | Unknown 25,000.00 at 30.00p |
| Day's Volume: | 196,385 |
| Last Close: | 30.00p |
| Open: | 31.50p |
| ISIN: | GB00BMC3RJ87 |
| Day's Range | 30.00p - 31.50p |
| 52wk Range: | 9.00p - 39.00p |
| Market Capitalisation: | £41.92m |
| VWAP: | 30.32691p |
| Shares in Issue: | 139.73m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Sareum (SAR) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 25,000 | 30.00p | Ordinary |
16:25:24 - 15-Sep-26 |
| Unknown* | 25,000 | 30.00p | Ordinary |
16:24:36 - 15-Sep-26 |
| Buy* | 32 | 31.00p | SI Trade |
16:24:25 - 15-Sep-26 |
| Buy* | 38 | 31.00p | SI Trade |
16:24:25 - 15-Sep-26 |
| Buy* | 129 | 31.00p | SI Trade |
16:24:25 - 15-Sep-26 |
| Sell* | 1,800 | 30.25p | Ordinary |
15:28:26 - 15-Sep-26 |
| Sell* | 2,914 | 30.30p | Ordinary |
14:41:20 - 15-Sep-26 |
| Sell* | 900 | 30.34p | Ordinary |
14:18:39 - 15-Sep-26 |
| Buy* | 1,161 | 31.00p | Ordinary |
14:16:44 - 15-Sep-26 |
| Buy* | 25,000 | 31.00p | Ordinary |
14:13:39 - 15-Sep-26 |
Sareum (SAR) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 2nd Sep 2026 5:29 pm | RNS | Exercise of Warrants |
| 19th Aug 2026 2:19 pm | RNS | Exercise of Warrants |
| 7th Aug 2026 1:28 pm | RNS | Exercise of Warrants |
| 20th Jul 2026 7:00 am | RNS | Completion of Dosing in Toxicology Programme |
| 22nd Jun 2026 9:40 am | RNS | Publication of Phase 1 data on SDC-1801 in BJCP |
| 1st May 2026 7:00 am | RNS | Exercise of Warrants |
| 12th Mar 2026 7:00 am | RNS | Half-Year Report for Six Months Ended 31 Dec 2025 |
| 12th Mar 2026 7:00 am | RNS | Half-Year Report for Six Months Ended 31 Dec 2025 |
| 3rd Mar 2026 7:00 am | RNS | Notice of Results and Investor Presentation |
| 17th Feb 2026 7:00 am | RNS | Restart of Phase 2-enabling toxicology programme |